Stockreport

Zenas BioPharma Seen Attractive Ahead of IgG4-RD Phase 3 Update, Wedbush Says [Yahoo! Finance]

Zenas BioPharma, Inc.  (ZBIO) 
PDF Zenas BioPharma (ZBIO) shares are seen as attractive ahead of the Phase 3 topline results for obexel [Read more]